Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11424155 | 1.00 | LMNA (0.42) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL640184 | 1.00 | LMNA (0.42) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL319408 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL3073599 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL2635052 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL517269 | 0.94 | LMNA (0.46) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Hydrochloric Acid SCHEMBL8587068 | 0.92 | LMNA (0.44) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL10534255 | 0.88 | LMNA (0.41) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Phosphoric Acid SCHEMBL5789520 | 0.87 | LMNA (0.39) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| Acetic Acid SCHEMBL7951061 | 0.87 | USP2 (0.44) | LMNAL3MBTL1TDP1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018106546-A1 | METHODS OF DETECTION OF ANTIBIOTIC-RESISTANT BACTERIA | SILVER LAKE RESEARCH CORPORATION (US) | 2018-06-14 | — | — | WO | claimed |
| US-20180156796-A1 | Methods of Detection of Antibiotic-Resistant Bacteria | SILVER LAKE RESEARCH CORPORATION (US) | 2018-06-07 | — | — | US | claimed |
| US-20260115279-A1 | Methods for Isolation of Lipid-Disc Compositions and Uses Thereof | VIB VZW (BE) | 2026-04-30 | — | — | US | disclosed |
| US-12593839-B2 | Fabric care composition comprising a mixture of cationic biocide, functionalized alkylpoyglycoside, and sulfolaurate salt | BROADOUS SR TIMOTHY (US) | 2026-04-07 | — | — | US | disclosed |
| US-12544435-B2 | Neisserial surface protein a (NSPA) variants and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-10 | — | — | US | disclosed |
| WO-2025264672-A1 | INHIBITORS OF MOBILIZED COLISTIN RESISTANCE ENZYME (MCR-1) AND METHODS OF USE THEREOF | BAYLOR COLLEGE OF MEDICINE (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4658292-A1 | PRODUCTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF PSEUDOMONAS INFECTIONS | The Administrators of The Tulane Educational Fund (US) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024163916-A9 | PRODUCTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF PSEUDOMONAS INFECTIONS | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20250154206-A1 | Factor H Binding Protein Variants and Methods of Use Thereof | CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND | 2025-05-15 | — | — | US | disclosed |
| US-12295965-B2 | Methods of treating sepsis using anti-sepsis lipid a (ASLA) based therapeutics | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2025-05-13 | — | — | US | disclosed |
| US-20250136648-A1 | Factor H Binding Protein Variants and Methods of Use Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-05-01 | — | — | US | disclosed |
| EP-0536302-A1 | IMPROVED ADJUVANTS AND VACCINES. | UNIV EMORY (US) | 1993-04-14 | — | — | EP | disclosed |
| EP-0466838-A1 | NOVEL LIPID A DERIVATIVES AND USES THEREFOR | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1992-01-22 | — | — | EP | disclosed |
| WO-1992000101-A1 | IMPROVED ADJUVANTS AND VACCINES | EMORY UNIVERSITY (US) | 1992-01-09 | — | — | WO | disclosed |
| US-5041427-A | Protection Against Gramnegative Endotoxin | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1991-08-20 | — | — | US | disclosed |
| WO-1991001134-A1 | NOVEL LIPID A DERIVATIVES AND USES THEREFOR | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1991-02-07 | — | — | WO | disclosed |
| EP-0143840-B1 | MONOSACCHARIDE COMPOUNDS HAVING IMMUNOSTIMULATING ACTIVITY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1990-08-29 | — | — | EP | disclosed |
| EP-0143840-A4 | MONOSACCHARIDE COMPOUNDS HAVING IMMUNOSTIMULATING ACTIVITY. | WISCONSIN ALUMNI RES FOUND (US) | 1986-02-13 | — | — | EP | disclosed |
| EP-0143840-A1 | MONOSACCHARIDE COMPOUNDS HAVING IMMUNOSTIMULATING ACTIVITY. | WISCONSIN ALUMNI RES FOUND (US) | 1985-06-12 | — | — | EP | disclosed |
| WO-1984004526-A1 | MONOSACCHARIDE COMPOUNDS HAVING IMMUNOSTIMULATING ACTIVITY | WISCONSIN ALUMNI RES FOUND (US) | 1984-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12295965-B2 | Methods of treating sepsis using anti-sepsis lipid a (ASLA) based therapeutics | S1PR1, ASS1, S1PR3 | LMNA 1773/4885L3MBTL1 1055/4885TDP1 3384/4885 |
| US-12593839-B2 | Fabric care composition comprising a mixture of cationic biocide, functionalized alkylpoyglycoside, and sulfolaurate salt | CUTA, MGAM, PLOD3 | LMNA 857/4885L3MBTL1 885/4885TDP1 1372/4885 |
| US-20260115279-A1 | Methods for Isolation of Lipid-Disc Compositions and Uses Thereof | STT3B, DDOST, PLTP | LMNA 989/4885L3MBTL1 851/4885TDP1 2178/4885 |
| US-12544435-B2 | Neisserial surface protein a (NSPA) variants and methods of use thereof | CFH, ASNS, PSPH | LMNA 797/4885L3MBTL1 1281/4885TDP1 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.